The Latest Cardiac and Vascular News
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced the publication of data in the Journal of Cardiovascular Electrophysiology (JACE) demonstrating vMap’s ability to reduce the time from mapping to treatment, procedure duration, and fluoroscopy when treating cardiac arrhythmia patients with ablation therapy. “A 22.6% reduction in […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. This funding underscores investor confidence in Vektor’s vision and ability to successfully execute its mission to revolutionize arrhythmia care. “The medical […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, a pioneer in arrhythmia care and developer of the only FDA-cleared non-invasive technology to accurately map arrhythmias using just 12-lead ECG data, is delighted to announce the expansion of its esteemed Medical Advisory Board. The newly expanded Medical Advisory Board, features preeminent electrophysiology leaders, including: Dr. […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ECG data, today announced the release of a series of software enhancements to its AI-based non-invasive solution, vMap. Designed to improve ablation outcomes and procedural efficiencies, the newly updated vMap software integrates additional automation […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the vMap® next-generation arrhythmia mapping technology, today announced former Philips and Biotronik medical technology leader Marlou Janssen and Yale Clinical Professor of Medicine and past American College of Cardiology (ACC) Connecticut Chapter Governor and President Dr. Craig McPherson have joined Vektor’s advisory board. With […]
Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s only technology to rapidly map arrhythmias using just 12-lead ECG data, today […]
Case studies highlighting vMap’s effectiveness at localizing arrhythmia termination sites in complex cases to be presented alongside vMap time study NEW ORLEANS–(BUSINESS WIRE)–Vektor Medical, developer of vMap® — the world’s first FDA-cleared technology to localize arrhythmias from just 12-lead ECG data — will present complex case studies that expand vMap’s utility […]
Positive efficiency results presented at American College of Physicians Southern California Chapters 1, 2, 3 Poster Competition and Scientific Program SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, announced study results that demonstrate a significant reduction in […]
Tim Laird joins as Vice President of Sales Kathryn Wilamowski joins as Senior Manager, Quality Systems SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map arrhythmias in all four heart chambers, including atrial and ventricular fibrillation, using only 12-lead ECG data, today announced the appointment of […]
Krummen to spearhead commercialization and product evolution of innovative arrhythmia mapping technology SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first rapid technology to non-invasively map arrhythmias in all four chambers of the heart, today announced the appointment of Rob Krummen as CEO. After five years serving as CEO, Mike Monko […]
